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The mTOR pathway is the central regulator of cell size 1 . External signals from growth factors and nutrients converge on the mTORC1 multi-protein complex to modulate downstream targets, but how the different inputs are integrated and translated into specific cellular responses is incompletely understood [2] [3] [4] . Deregulation of the mTOR pathway occurs in polycystic kidney disease (PKD) [5] [6] [7] , where cilia (filiform sensory organelles) fail to sense urine flow because of inherited mutations in ciliary proteins 8 . We therefore investigated if cilia have a role in mTOR regulation. Here, we show that ablation of cilia in transgenic mice results in enlarged cells when compared with control animals. In vitro analysis demonstrated that bending of the cilia by flow is required for mTOR downregulation and cell-size control. Surprisingly, regulation of cell size by cilia is independent of flow-induced calcium transients, or Akt. However, the tumour-suppressor protein Lkb1 localises in the cilium, and flow results in increased AMPK phosphorylation at the basal body. Conversely, knockdown of Lkb1 prevents normal cell-size regulation under flow conditions. Our results demonstrate that the cilium regulates mTOR signalling and cell size, and identify the cilium-basal body compartment as a spatially restricted activation site for Lkb1 signalling.
The mammalian target of rapamycin (mTOR) pathway has a crucial role in metabolism and cell growth 1 . mTOR signalling is executed by two multiprotein complexes, mTORC1 and mTORC2. mTORC1 is activated by the GTPase Rheb to phosphorylate p70S6 kinase (S6K) and 4E-BP1 and thereby stimulate protein synthesis, but is effectively inhibited by treatment of cells with rapamycin. mTORC1 activity is regulated by diverse signals [2] [3] [4] . Growth factors and amino acids activate mTORC1, whereas energy stress and the tumour suppressor Lkb1 inhibit mTORC1-mediated signalling through the energy sensor, AMP-activated protein kinase (AMPK) 9 .
Although knowledge of intracellular signal-transduction events is rapidly increasing, little information exists on where different external signals are processed to regulate mTOR signalling 4 . We hypothesized that cilia have a role in mTOR signalling. Cilia are signalling platforms that protrude as filiform organelles from the plasma membrane, and rely on kinesin-driven intraflagellar transport (IFT) for their form and function 10, 11 . They function as mechanosensors, which generates calcium currents 12 , have a pivotal role in the hedgehog pathway 13, 14 and are involved in Wnt signalling 15 . Mutations of ciliary proteins result in developmental defects, including situs-inversus and polydactyly, and postnatal diseases, such as retinal degeneration, obesity and polycystic kidney disease (PKD) 8 . In PKD the tubular geometry of kidneys is distorted and fluid-filled cysts replace renal parenchyma 16 . One hypothesis of why tubular cells are unable to maintain the tubular diameter is that there is a failure by the cilia to sense urine flow 17 ; however, the downstream effects of flow sensing are unknown. Cyst epithelia have increased mTORC1 activity 7 . Interestingly, mTOR inhibitors markedly reduce cyst formation in PKD animal models [5] [6] [7] , and are currently being tested in clinical trials 18, 19 . However, the mechanism of mTOR deregulation in PKD is not established. Polycystin-1, the most commonly mutated protein in autosomal dominant PKD (ADPKD), interacts with mTOR 7 and reduces mTORC1 activity 20 , but the role of cilia in mTOR regulation has not been investigated.
In polycystic kidneys, cells lining the cysts are larger than normal tubular cells 21 , raising the possibility that cilia have a role in cell-size control. To determine whether the loss of primary cilia affects cell size in vivo, we measured cell volumes in renal collecting ducts of mouse kidneys with a mutation in the kinesin subunit, Kif3a 22 . These mice lose cilia by postnatal day 10 (P10) and start to form cysts at P14 (ref. 22) . The collecting duct cells of Kif3a mutants were larger than cells in control animals (Fig. 1a) and the size distribution of Kif3a-mutant cells was shifted to the right (Fig. 1b) , suggesting that primary cilia have a role in the regulation of cell volume.
To facilitate the study of how cilia regulate cell size, we generated MDCK cells with inducible knockdown of Kif3a (Kif3a-i). On incubation of these cells with tetracycline, Kif3a is knocked down and GFP (green fluorescent protein) is expressed (Fig. 1c) . Immunostaining for acetylated tubulin, a cilia marker, confirmed that GFP-positive knockdown cells lack cilia ( Fig. 1d and Supplementary Information, Fig. S1a ). However, in contrast to the in vivo findings, no size difference was seen in Kif3a-depleted cells, compared with non-induced control cells (Fig. 1e) . This discrepancy suggested that physiological requirements for cell-size control were missing in the in vitro experiment. In renal tubules, cilia function as flow sensors 12, 23 , so we hypothesized that bending of the cilia by fluid flow might be the physiological stimulus that regulates cell size. To test this hypothesis, we analysed ciliated MDCK cells in a flow chamber that allows cultivation of cells for several days under permanent fluid flow, mimicking the physiological conditions in renal tubules 24 . Interestingly, after 6 days under flow conditions the average cell size appeared smaller than in cells grown without flow (Fig. 1f, g ). To further validate this finding, we performed a time-course analysis and found that cell size decreases between day 1 and 4, but with no further decrease from day 4 to 8 ( Fig. 1h and Supplementary  Information, Fig. S1b ). Cells in stationary medium also reached a plateau after 4 days, but remained significantly larger, despite a similarly low mitotic index 24 ( Supplementary Information, Fig. S1c ). Further analysis of cross-sections was performed to ensure that differences in the x-y plane are not offset by different cell heights, but no difference was found in z-axis measurements ( Supplementary Information, Fig. S1d, e) . Similarly, three-dimensional (3D) volume estimation of membrane-labelled cells demonstrated that cells under flow were significantly smaller than controls (Fig. 1i, j) . These findings raised the possibility that cilia require flow to regulate cell size. Indeed, when Kif3a-i cells were analysed in the flow chamber the cell size of Kif3a-depleted cells was significantly larger than non-induced cells ( Fig. 1k and Supplementary Information, Fig. S1f ). Thus, our in vitro findings in the flow chamber mimic the deregulation of cell size in Kif3a-mutant mice and demonstrate that bending of cilia by flow is critical for cell size regulation.
We tested our hypothesis in a second cilia-deficient cell line, as Kif3a has known extra-ciliary functions To test whether cilia regulate cell size through the mTOR pathway, we analysed cell lysates from ciliated MDCK cells for phosphorylation of mTOR and its target S6K, established markers of mTORC1 actvity 28 . We found that cells under flow had less phosphorylated mTOR and S6K when compared with cells in stationary medium (Fig. 2a-d the decreased cell size. Conversely, the levels of phosphorylated mTOR and S6K increased after depletion of Kif3a in cells grown under flow (Fig. 2e-h ), which corresponds to the larger size of these cells, compared with control cells. We hypothesized that flow represses mTORC1 in ciliated cells, and that cells without cilia fail to downregulate mTOR. Indeed, in ciliated Kif3a-i cells after 5 days under flow, phosphorylated S6K was decreased, compared with baseline before flow, whereas in Kif3a-i cells induced with tetracycline and therefore unciliated, the downregulation of phosphorylated S6K was less pronounced (Fig. 2i) . Analogous results were obtained in Ift88-i cells (Fig. 2j, k) , but not in control lines ( Supplementary Information, Fig. S2h , i). Similarly to our in vitro data, Kif3a mutant kidneys contained more phosphorylated ribosomal-S6-protein (rS6), an S6K target, than kidneys from control animals (Fig. 2l, m) and epithelial phosphorylated rS6 staining was found in mutant mice but not in controls (Fig. 2n) . These results confirm a positive correlation between cell size and mTORC1 activity and suggested that the cell size changes are mediated through cilia-dependent downregulation of the mTOR pathway.
To further test if cell-size regulation in vitro occurs through mTOR we treated ciliated cells under flow with rapamycin 29 . Compared with vehicle-treated cells, rapamycin had no effect on the size of ciliated Kif3a-i cells (Kif3a-i cells without tetracycline; Fig. 3a) suggesting that flow maximally suppresses mTORC1 activity in ciliated cells. However, in unciliated cells, rapamycin compensated for the absence of cilia and resulted in smaller cells (Kif3a-i cells with tetracycline; Fig. 3a, b) . In a complementary approach, co-expression of dominant-negative Raptor, a scaffold protein of mTORC1 29, 30 , or Raptor knockdown, in Kif3a-depleted cells, resulted in a similar size decrease under flow as in ciliated cells ( Fig. 3c and Supplementary Information, Fig. S3a, b) and thus demonstrated that the size defect with absent cilia is because of ineffective downregulation of mTORC1.
Using an opposite approach, we reasoned that activation of mTOR would counteract the flow-mediated cell-size reduction. We transduced MDCK cells with a tetracycline-inducible gain-of-function mutant of the mTORC1 activator, Rheb 31 (Rheb S16H ; Supplementary Information,  Fig. S3c ). Induction of this construct activated mTOR (Fig. 3d, e) and resulted in significantly larger cells under flow than the same cells without induction (Fig. 3f, g ). These results demonstrate that mechanical stimulation of cilia downregulates the mTOR pathway and cell size.
After establishing a link between cilia, mTOR and cell size, we were interested in the underlying mechanism. Protein kinase B (Akt) is a major activator of mTOR. Akt activates mTORC1 directly, as well as indirectly by releasing Rheb from inhibition by the Tsc complex 2 . We hypothesized that if mTOR deregulation through lack of cilia involved Akt activation, loss of Akt function would rescue the phenotype. However, expression of a dominant-negative Akt mutant in Kif3a-depleted cells neither abrogated cell-size deregulation nor S6K phosphorylation under flow ( Supplementary Information, Fig. S3d-f ), suggesting that a role for Akt in ciliary mTOR regulation is unlikely.
The mechanosensory function of cilia in the kidney involves the cation channel polycystin-2 (TRPP2), which is mutated in a subset of patients with ADPKD. TRPP2 translates fluid flow into calcium transients 17 . However, it is unclear if deficient flow-mediated calcium transients have a role in cyst formation 32 . We hypothesized that inhibition of the mTOR pathway through ciliary bending might be mediated by a calcium signal. Ciliated MDCK cells are a well-established model to analyse calcium signalling under flow 12, 23 . Consequently, we generated tetracycline-inducible TRPP2 knockdown cells. Tetracycline induction of these cells resulted in efficient depletion of TRPP2 ( Supplementary  Information, Fig. S3g ) and inhibited flow-induced calcium transients (Fig. 3h, i and Supplementary Information, Fig. S3h) . Surprisingly, in cells grown under flow conditions, no difference was found in cell size or levels of phosphorylated S6K after knockdown of TRPP2, compared with control cells (Fig. 3j, k and Supplementary Information, Fig. S3i, j) . This finding indicated that cell size and mTORC1 control by cilia occurs independently of flow-induced calcium signalling.
Next, we investigated the tumour suppressor, Lkb1, a negative regulator of mTOR 9, 33 . In fact, loss of Lkb1 increases cell mass in pancreatic β-cells through activation of mTOR 34 . To test if Lkb1 has a role in the ciliary regulation of cell size, we generated MDCK cells with tetracycline-inducible knockdown of Lkb1 (Fig. 4a) . Similarly to previous observations depletion of Lkb1 in MDCK cells did not affect markers of apico-basal cell polarity or cilia formation ( Fig. 4b and Supplementary Information,  Fig. S4 ). As expected, phosphorylation of AMPK, the target of Lkb1, was significantly decreased ( Supplementary Information, Fig. S5a, b) , thus validating the knockdown approach. Similarly to unciliated cells, Lkb1-depleted cells showed no difference in size when compared with non-induced cells, in the absence of flow (Fig. 4c) . However, when subjected to flow, Lkb1-i cells were significantly larger than the controls without induction (Fig. 4d) . Similar results were obtained in cells expressing dominant-negative mutant Lkb1 36 (Lkb1
D194A
; Fig. 4c, d and Supplementary Information, Fig. S5c ), confirming that Lkb1 has a role in cell-size regulation under flow. The phosphorylation of S6K was increased in Lkb1 knockdown cells under flow (Fig. 4e, f) demonstrating that the size increase of Lkb1-deficient cells is accompanied by mTOR activation. Notably, expression of Lkb1 ( Supplementary Information, Fig. S5d ) in unciliated Kif3a-depleted cells did not rescue the absent-cilia phenotype ( Fig. 4g and Supplementary Information, Fig. S5e ) and suggested that cilia are required for Lkb1 activation.
We then investigated the link between Lkb1 and the cilium. Lkb1 was present in cilia and the basal body, as visualized by immunostaining (Fig. 4h, i) and by overexpression of an Lkb1-YFP (yellow fluorescent protein) fusion protein (Fig. 4j, k and Supplementary Information,  Fig. S5f ). We hypothesized that the bending of cilia may activate the Lkb1 pathway, but levels of phosphorylated AMPK in whole cell lysates were similar in cells grown under flow and without ( Supplementary  Information, Fig. S5g, h ). Strikingly, we found an intense accumulation of phosphorylated AMPK at the basal body (Fig. 5a-c) . Furthermore, quantitative image analysis revealed that phosphorylated AMPK was significantly increased at the basal body of cells under flow, compared with cells grown in stationary medium (Fig. 5d, e) . In summary, these findings demonstrate that bending of the cilium by flow activates the Lkb1 pathway in the cilia-basal body compartment to inhibit mTORC1 activity and cell size ( Fig. 5f for schematic representation of a model).
Our data establish that cilia function as regulators in the mTOR signalling cascade and provide important insight into the mechanism of how extracellular signals are transduced to regulate mTOR activity. It is currently unclear how input-output specificity is achieved for a large number of extracellular signals that are translated into different mTOR effectors 4 . Our data suggest that the cilia-basal body compartment is where the Lkb1 pathway is activated on mechanical engagement of the cilium, and thus provide evidence of a spatially restricted regulatory site for mTOR signalling. Our data further demonstrate that, apart from calcium transients, mTOR regulation by Lkb1 in the cilium-basal body compartment represents an independent mechanosensory signal transduction mechanism that translates shear stress through bending of the cilium into cellular programmes. Our findings raise the intriguing question of whether cell size is important for tubular geometry of the kidney. Previous evidence links cell shape and surface tension with complex cellular programmes and morphogenesis 37 . Perfusion studies have shown that fluid flow and shear forces depend on tubular diameter 38 . It is conceivable that larger cells change the tubular diameter and thereby alter flow sensing. Whether cell-size-mediated changes in shear stress contribute to cyst formation remains to be shown in future work. Recent data indicate that polycystin 1 downregulates mTOR independently of flow 20 , suggesting that other pathways exist to modulate mTOR in renal epithelial cells.
It is possible that the cilium might have a role in mTOR signalling in contexts other than mechanotransduction. The cilium is a signalling organelle equipped with an intraflagellar transport system providing fast access for signalling molecules to a restricted compartment ideally suited for environmental sensing 11 , such as light in photoreceptors, smell in odorant receptors, and the regulation of Hedgehog and Wnt signalling 11 . Interestingly, the glucose transporter, Glut2, is localized in ependymal cilia in the brain 39 . Furthermore, cilia-deficient mice have impaired metabolic control after glucose challenge 40 , thus providing the basis for a functional link between glucose metabolism and cilia. Insulin signalling activates mTORC1 and glucose control is, at least in part, regulated by Lkb1 and AMPK in a complex mechanism that is not fully understood 34 . Together with these findings our results raise the possibility that, beyond mechanosensation, cilia may have a broader role in metabolic control through Lkb1, AMPK and mTOR signalling. 
M E T H O D S

METHODS
Animals and in vivo cell volume measurements. Kidney-specific Kif3a-mutant mice were produced as described 22 . Briefly, Pkhd1-Cre transgenic mice expressing Cre recombinase under the control of the Pkhd1 promoter were crossed with Kif3a flox/-mice, and the resulting progeny were intercrossed to generate Pkhd1-Cre; Kif3a flox/-mice (the Kif3a mutant). Pkhd1-Cre; Kif3a flox/+ or Kif3a +/-littermates were used as controls. Mice were killed at postnatal day 16, and the kidneys were fixed and sectioned as described 22 . All experiments involving animals were performed under the auspices of the UT Southwestern Institutional Animal Care and Research Advisory Committee.
Tissue cryosections (6 μm thick) were co-stained with antibody against aquaporin-3 and FITC (fluorescein isothiocyanate)-coupled Dolichos biflorus agglutinin (DBA). Sections were prepared as previously described 22 . Images of the stained sections were acquired using an LSM 510 META laser scanning confocal microscope (Carl Zeiss MicroImaging GmbH). Mutant and control kidneys were imaged under identical magnification and exposure conditions. 3D images were reconstructed from z-stack images using Imaris software (Bitplane, Zurich, Switzerland). Single collecting duct cells stained with DBA and aquaporin-3 antibody were selected by cropping, and the cell volume was measured using Imaris software. Sections from mice for immunofluoresence microscopy staining of phosphorylated ribosomal S6 protein were obtained at postnatal day 21.
Transgenic cell lines. EB1-YFP has been previously described 24 . For inducible knockdown of Kif3a, Ift88, TRPP2, Lkb1 and Raptor, MDCK cells were first transduced with lentivirus encoding the tetracycline-sensitive tTR-KRAB repressor and a DsRed reporter 41 . Cells were then transfected with lentivirus encoding the specific shRNA, and a GFP reporter, (pLVTH vector), both under the control of tTR-KRAB. Target sequences: Kif3a (5ʹ-AGGCTAGAGCTGAATTAGAG-3ʹ), Ift88 (5 ʹ-GAAGGCAGCTGAATTCTAT-3ʹ), TRPP2 (5ʹ-GGAGG AGGCAA-GTTA AACT-3ʹ), Lkb1 (5ʹ-GCTGGTGGACGTGTTATAC-3ʹ) and Raptor (5ʹ-GGCT AGTCTGTTTCGAAATTT-3ʹ). Empty-vector control cells were obtained in the same way but lentivirus for the second transduction was prepared with pLVTH vector without shRNA, but still expressing GFP. Luci-i cells were obtained identically to Kif3a-i, with shRNA specific to luciferase (target sequence: 5ʹ-CGTACGCGGAATACTTCGA-3ʹ). To generate cells expressing the constitutively active Rheb mutant, mutant Rheb (Rheb S16H ; construct was a gift from R. Lamb, University of Alberta, Canada) 31 was cloned into empty pLVTH vector in-frame with amino-terminal CFP (cyan fluorescent protein) after excision of GFP, and lentiviral transduction was performed as described above. Lkb1-YFP was cloned from canine cDNA into pLXSN in-frame with N-terminal Venus, a variant of the yellow fluorescent protein 42 , and stably expressed in MDCK cells after retroviral transduction. To generate Kif3a-i cells overexpressing Lkb1, canine Lkb1 was cloned into the GFP cassette of pLVTH and transduced by lentivirus into Kif3a-i cells. Dominant-negative Lkb1 D194A was acquired through site-directed mutagenesis. Dominant-negative Raptor 43 was generated by deleting the carboxy terminus of human Raptor (Addgene plasmid #1859) with primers (5ʹ-ATGGAGTCCGAAATGCTGCAA-3ʹ and 5ʹ-CGAGACTTGCCTTCTGGCCGGTGA-3ʹ), and it was then cloned into pLVTH. The same was done for mouse dominant-negative AKT (construct was a gift from L. Cantley, Harvard Medical School, USA) 44 . Antibodies, reagents, western blots and band quantification. For immunofluorescence microscopy staining, the following antibodies were used: antiaquaporin-3 (1:400; Chemicon International), FITC-coupled Dolichos biflorus agglutinin (DBA, 1:400; Vector Laboratories), anti-Lkb1 (1:400; 27D19, Cell Signalling), anti-Zo-1 (1:400; #40-2200, Invitrogen), anti-acetylated tubulin Antibodies were visualized using Cy5-, Cy3-or Alexa-488-labelled secondary antibodies (1:1000; Jackson Immunoresearch) and Fluor 594-coupled goat antirabbit IgG (immunoglobulin G; 1:400). Hoechst 33342 was used for staining nuclei. Rapamycin (553211, Calbiochem) was solubilized in vehicle (DMSO) and used at 100 nM.
For western blotting, the following antibodies were used (1:1,000 dilution and from Cell Signaling unless otherwise indicated): anti-phospho-mTOR (Ser 2448) (2971), anti-total mTOR (2972), anti-phospho-AMPK (2535), anti-total AMPK (2532), anti-p70S6 kinase (9202), anti-phospho-p70S6 kinase (9205), anti-phospho-S6 ribosomal protein (4857), anti-Raptor (4978), anti-Lkb1 (27D10), anti-V5 (MCA1360, Serotec), anti-GFP (SC9996, Santa Cruz), anti-CFP (S98, MBL), anti-γ-tubulin (1:3,000; T6557), anti-actin (1:5,000; A1978, both Sigma-Aldrich) and anti-Kif3a (611508, BD Transduction Labs). Monoclonal anti-TRPP2 (1:800) was raised against amino-acid residues 698-799 of human TRPP2 in collaboration with Nanotools (www.nanotools.de). Cells were grown in 10 cm cell-culture dishes. Cell lysis and western blot were performed as previously described 24 . Preparation of lysates from the flow chambers was done with urea buffer (8 M Urea, 10 mM Tris-HCl at pH 8.0, 100 mM Na 2 HPO 4 /NaH 2 PO 4 and 0.2% (v/v) Triton X-100). Before blotting, the membranes were fixed in glutaraldehyde. Quantification of non-saturated bands was performed using ImageJ (http://rsb.info.nih.gov/ij/).
Immunofluorescence microscopy staining. For staining of cilia, cells were grown on glass coverslips for 10 days. The cells were fixed and immunofluorescence microscopy staining was performed as previously described 24 . For improved rendering of images acquired by epifluorescence microscopy, gamma adjustments were performed in Photoshop for Figure 1d and Supplementary Information Figure S1j . For the tight junction (staining with anti-Zo-1 and anti-Par3) and adherence junction (staining with anti-β-Catenin, anti-E-cadherin and antiScribble) staining, cells were grown for 2 days.
Phosphorylated AMPK quantification at the basal body was performed using an inverted laser-scanning microscope. Within the cell monolayer (5 days , and allowed to adhere for 24 h. The chamber was then connected to a computer-controlled setup containing an air-pressure pump and a two-way switching valve (Ibidi pump system 10902), pumping 40 ml of phenol-red-free cellculture medium unidirectionally between two reservoirs through the flow channel at a rate of 1.0 or 0.6 ml min -1 (Microslide I or VI), corresponding to a shear stress of approximately 0.75-1 dyn per cm 2 . Each day, single plane images were randomly recorded (Axiovert 200M, Zeiss) at ten locations with a C-Apochromat ×63, 1.2 W objective for differential interference contrast (DIC) microscopy, or YFP, images. YFP excitation was performed with 490-510 nm and emission was collected by using a filter combination of Q515LP and HQ535/30 (AHF).
The mean cell size was calculated by counting cells manually in a defined area of 2700 μm 2 in the centre of full-frame images, using Imaris software. Fully visible cells were counted as one, cells at the top and right margins were counted when ≥ 50% was visible and at the bottom and left margins cells were counted when ≥ 90% was visible. The mean cell size in a visual field was obtained by dividing the area size by the number of counted cells in each visual field. Ten visual fields were analysed in each flow channel once, after day 5, during the plateau phase.
For cell-height measurements, EB1-YFP, Kif3a-i and Ift88-i cell lines were grown under flow and non-flow conditions. Cell height was analysed using an inverted laser scanning microscope (LSM 510 Meta Duo Live) equipped with a Plan-Apochromat ×40/1.2 N.A. water objective. Within the cell monolayer 5-6 random fields of view (225 × 225 μm) for each condition were selected and z-stacks (33-54 z-planes, 0.5 μm z-distance, pixel time 1.28 μs) were recorded. 3D reconstruction and measurements were performed using LSM 510 Software (Version 4.2, Zeiss).
Fura2 ratio imaging was performed as previously described 23 . Briefly, ciliated cells grown on coverslips for 7-10 days were incubated with fura-2 AM (10 μM) and Probenecid (1 mM) and inserted into the parallel-plate flow chamber. Ratio imaging was performed in temperature-controlled conditions under an inverted microscope (Axiovert 200M, Zeiss).
Mitotic indices were calculated as previously described 24 . Briefly, MDCK cells stably expressing EB1-YFP were grown under flow and non-flow conditions. EB1 aggregates at mitotic spindles, which were counted daily together with the total number of cells (field of view size 14,477 μm Supplementary  Information, Fig. S6 . Figure S4 Lkb1 knock-down cells (+tet) and non-induced controls (-tet) were fixed and stained for the apical protein GP135, the tight junction proteins Zo-1 and Par3, and the lateral markers ß-Catenin, E-cadherin and Scrib. Apart from a slight reduction of E-cadherin staining, no differences are observed in Lkb1 depleted cells (+tet). Scale bars 10μm. 
